Test Overview
Test Methodology

Next gen sequencing

Test Usage

FDA-approved tumor test that determines HRD status using BRCA status and Genomic Instability Status in patients with ovarian cancer

Reference Range *

Interpretive report provided

* Reference ranges may change over time. Please refer to the original patient report when evaluating results.

Test Details
Days Set Up
Monday - Friday
Analytic Time

14 - 21 days

Soft Order Code
MYRMC
Synonyms
    Laboratory
    Sendout
    Reference Laboratory
    Myriad Genetics
    Section
    Special Testing
    Specimen Requirements
    Special Handling

    There are test kits supplied by the company to be used for shipping the block/slides. Sendouts only has 1 in stock, please contact the company to order kits if needed.

    Normal Volume
    40 microns of tumor, at least 20% of tumor in the block chosen by a pathologist
    Storage Temperature
    Ambient
    Additional Information

    Test performed by Myriad Genetics- Oncology

    Billing
    NY State Approved
    No